SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-066376
Filing Date
2021-05-14
Accepted
2021-05-14 07:52:40
Documents
57
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2111684d1_10q.htm 10-Q 516117
2 EXHIBIT 31.1 tm2111684d1_ex31-1.htm EX-31.1 8250
3 EXHIBIT 32.1 tm2111684d1_ex32-1.htm EX-32.1 5742
  Complete submission text file 0001104659-21-066376.txt   4723739

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT lptx-20210331.xml EX-101.INS 1117800
5 XBRL TAXONOMY EXTENSION SCHEMA lptx-20210331.xsd EX-101.SCH 42865
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lptx-20210331_cal.xml EX-101.CAL 43004
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lptx-20210331_def.xml EX-101.DEF 166820
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20210331_lab.xml EX-101.LAB 417564
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20210331_pre.xml EX-101.PRE 309919
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 21921965
SIC: 2834 Pharmaceutical Preparations